GT
TRNS icon

Glenmede Trust’s Transcat TRNS Stock Holding History

Glenmede Trust’s Portfolio TRNS Stock Details TRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,816
Closed -$207K – 1573
2026
Q1 		$207K Sell
2,816
-1,984
-41% -$140K ﹤0.01% 1299
2025
Q4 		$272K Buy
+4,800
New +$299K ﹤0.01% 1179
2025
Q1 		$355K Buy
4,763
+435
+10% +$36.5K ﹤0.01% 1021
2024
Q4 		$458K Sell
4,328
-265
-6% -$29.4K ﹤0.01% 966
2024
Q3 		$555K Buy
4,593
+675
+17% +$83.9K ﹤0.01% 904
2024
Q2 		$469K Buy
3,918
+110
+3% +$13K ﹤0.01% 936
2024
Q1 		$424K Buy
3,808
+455
+14% +$48.2K ﹤0.01% 967
2023
Q4 		$367K Buy
3,353
+3
+0.1% +$289 ﹤0.01% 990
2023
Q3 		$328K Sell
3,350
-20
-0.6% -$1.91K ﹤0.01% 964
2023
Q2 		$301K Hold
3,370
– – ﹤0.01% 990
2023
Q1 		$301K Sell
3,370
-40
-1% -$3.4K ﹤0.01% 995
2022
Q4 		$242K Sell
3,410
-22
-0.6% -$1.68K ﹤0.01% 1039
2022
Q3 		$259K Buy
+3,432
New +$237K ﹤0.01% 1003

Other funds holding TRNS

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Glenmede Trust's TRNS Position: Q2 2026 in Review

Glenmede Trust sold out of Transcat (TRNS) in Q2 2026, closing a stake of 2,816 shares — an estimated $207K sold.

Glenmede Trust first reported a position in TRNS in Q3 2022 and held it in 13 quarters. The position peaked at $555K in Q3 2024. 172 funds tracked by Wall St. Rank hold TRNS as of Q2 2026.

  • Glenmede Trust reported no remaining Transcat position as of Q2 2026 after selling out during the quarter.
  • Glenmede Trust sold 2,816 Transcat shares in Q2 2026, an estimated $207K.
  • Glenmede Trust first reported a position in Transcat in Q3 2022 and held it in 13 quarters.
  • Glenmede Trust's Transcat position peaked at $555K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Transcat as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.